Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Statement re Chairman Appointment

16 Sep 2021 14:25

Β 

Appointment of Non-Executive Chair Designate

Ralph Findlay to join as Chair designate in March 2022 and succeed Steward Gilliland in July 2022

Dublin, London: C&C Group plc (β€˜C&C’ or the 'Group’), a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits and soft drinks across the UK and Ireland, are pleased to announce the appointment of Ralph Findlay as a director and Chair designate. Mr Findlay will join the Board on 1 March, 2022 as a Non-Executive Director and will succeed Stewart Gilliland as Chair following C&C’s Annual General Meeting ('AGM') in July 2022. Mr Gilliland had previously announced his intention to step down from the Board at the 2021 AGM.

Mr Findlay’s appointment follows a thorough evaluation and succession process led by the Nomination Committee, in conjunction with independent executive search firm, Spencer Stuart. Mr Findlay brings significant industry and listed company experience to the C&C Board.

Retirement of Stewart GillilandStewart Gilliland was appointed a Non-Executive Director of the Group in April 2012 and as Chair in July 2018. Under his leadership the Group has developed significantly, successfully integrating and optimising the Matthew Clark and Bibendum businesses, diversifying Board membership, and leading the Group’s response to the challenges of COVID-19.

Appointment of Ralph FindlayRalph Findlay brings extensive drinks industry experience to C&C. He has served as Chief Executive Officer of Marston’s, the UK pub group, since 2001 and will retire from that role on 2 October, 2021. Most recently, Ralph guided Marston’s through the successful sale of its brewing business into a Β£780m joint venture with Carlsberg in May 2020. Ralph has served on the Marston’s Board since 1996, having previously held the role of Finance Director before being appointed Chief Executive Officer in 2001. Ralph was appointed a Non-Executive Director of Vistry Group plc in 2015 and has served as Senior Independent Director since January 2020. He also previously served as Chair of the British Beer and Pub Association (BBPA).

Stewart Gilliland, C&C Chair, said: "It has been a pleasure working as part of the C&C business for the last nine years. During my tenure as Chair, the Group has transformed into the leading final-mile supplier to the on-trade in the UK and Ireland and had to navigate through the most challenging period in our industry’s history. I am privileged to have worked with such a talented and committed team who have managed these challenges so effectively and positioned the business to perform as we emerge from the pandemic. I look forward to welcoming Ralph to the Board next year and wish him every success for the future as the Group’s next Chair.”

Vincent Crowley, Senior Independent Director, said: "Ralph brings extensive industry experience to the Board and we are delighted to welcome him to C&C. He held a senior role at Marston’s for 25 years and has a deep understanding of the beverage and hospitality sector in the UK, one of our core markets, and internationally. He also brings extensive listed company board experience. We look forward to working with Ralph and drawing on his insight and expertise in the years ahead.”.

"On behalf of the Board, and the entire Group, I would also like to extend our gratitude to Stewart for his contribution to C&C over the past nine years and in particular for his guidance and leadership during his tenure as Chair. We will wish him well for the future when the time comes for him to hand over to Ralph."

Ralph Findlay said: "It is an exciting time to be joining C&C and I am very much looking forward to working with the Board and the wider team. C&C has iconic brands and a market leading distribution capability in the UK and Ireland. I am pleased to have the opportunity to play a role in driving the future success of the business for all our stakeholders including customers, consumers and shareholders.”

ENDS

Contacts

C&C Group plcPatrick McMahon, Chief Financial OfficerEwan Robertson, Finance and Investor Relations DirectorEmail: ewan.robertson@candcgroup.com

FTI ConsultingJonathan Neilan/Paddy BerkeryTel: +353 86 231 4135 / +353 86 602 5988Email: CandCGroup@fticonsulting.com

Novella CommunicationsTim RobertsonTel: +44 203 151 7008Email: TimR@novella-comms.com

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

β€’ C&C Group’s portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, super-premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent’s brands to over 40 countries worldwide.

β€’ C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.

β€’ C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating under the Matthew Clark, Bibendum, Tennent’s and Bulmers Ireland brands, the Group supplies over 35,000 pubs, bars, restaurants and hotels, and is a key route-to-market for major international beverage companies.

β€’ C&C Group also has a minority investment in the Admiral Taverns tenanted pub group, which owns over 1,600 pubs across England, Scotland and Wales.

C&C Group is a FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

Note to Editors

All remuneration arrangements for Ralph Findlay are consistent with the terms of the Directors' Remuneration Policy approved by shareholders at the AGM in July 2021. As a Non-Executive Director, Ralph Findlay will receive a fee of €65,000 and on his appointment as Chair will receive a fee of €250,000. The Board have determined that, upon appointment, Ralph will be independent.

There are no other matters to disclose under Listing Rule 9.6.13

View source version on businesswire.com: https://www.businesswire.com/news/home/20210916005513/en/

Copyright Business Wire 2021

Date   Source Headline
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company
6th Dec 20233:30 pmRNSDirectorate Change
5th Dec 20232:10 pmRNSBlock listing Interim Review
4th Dec 202311:15 amRNSTotal Voting Rights and Capital
16th Nov 20236:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20232:56 pmRNSHolding(s) in Company
2nd Nov 202312:44 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSTotal Voting Rights
30th Oct 20233:45 pmRNSDirector/PDMR Shareholding
26th Oct 20237:00 amBUSHalf-year Report
16th Oct 20235:16 pmRNSDirector/PDMR Shareholding
6th Oct 202312:30 pmRNSHolding(s) in Company
27th Sep 20233:56 pmRNSHolding(s) in Company
19th Sep 20237:00 amBUSStatement re FY2024 H1 pre-close Trading Statement
15th Sep 20232:10 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSDirectorate Changes
18th Aug 20239:35 amRNSDirector Declaration
16th Aug 20234:15 pmRNSDirector/PDMR Shareholding
20th Jul 20239:00 amRNSDirector Declaration
17th Jul 20233:15 pmRNSDirector/PDMR Shareholding
13th Jul 20231:00 pmRNSResult of AGM
13th Jul 20237:00 amBUSAGM Statement
6th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 20235:45 pmRNSHolding(s) in Company
26th Jun 202312:06 pmRNSHolding(s) in Company
16th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20236:05 pmRNSDirector/PDMR Shareholding
14th Jun 20238:30 amRNSAnnual Report & Notice of AGM
13th Jun 20234:30 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBlock listing Interim Review
30th May 20237:00 amRNSHolding(s) in Company
26th May 202312:15 pmRNSDirector/PDMR Shareholding
24th May 20231:45 pmRNSDirector/PDMR Shareholding
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.